Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 589-593

  Schwartz, Michael W ^a,b   Peskind, Elaine ^a,b   Raskind, Murray ^a,b   Boyko, Edward J ^a,b   Porte Jr , Daniel ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL TRANSPORT; BLOOD; BODY MASS INDEX; CEREBROSPINAL FLUID; FEMALE; HUMANS; LEPTIN; MALE; OBESITY; PROTEINS; REGRESSION ANALYSIS;

EID: 0029881125     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-589     Document Type: Article

References (18)

1. Halaas, J.L. et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546 (1995).
2. Stephens, T.W. et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377, 530-532 (1995).
3. Weigle, D.S. et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J. Clin. Invest. 96, 2065-2070 (1995).
4. Campfield, L.A., Smith, F.J., Gulsez, Y., Devos, R. & Burn, P. Mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks. Science 269, 546-549 (1995).
5. Pelleymounter, M.A. et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269, 540-543 (1995).
6. Maffei, M. et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob mRNA in obese and weight reduced subjects. Nature Med. 1, 1155-1161 (1995).
7. Considine, R.V. et al. Serum immunoreactive leptin concentrations in normal weight and obese humans. N. Engl. J. Med. 334, 292-295 (1996).
8. McKhann, G. et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944 (1984).
9. Kleinbaum, D.G., Kupper, L.L. & Muller, K.E. Applied Regression Analysis and Other Multivariable Methods. 232-233 (PWS-Kent Publ. Co., Boston, Massachusetts, 1988).
10. Kuczmarski, R., Flegal, K., Campbell, S. & Johnson, C. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 272, 205-211 (1994).
11. Frederich, R.C. et al. Expression of OB mRNA and its encoded protein in rodents. J. Clin. Invest. 96, 1658-1663 (1995).
12. Tartaglia, L.A. et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83, 1263-1271 (1995).
13. Baura, G. et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo: A mechanism for regulated insulin delivery to the brain. J. Clin. Invest. 92, 1824-1830 (1993).
14. Pardridge, W.M. Receptor-mediated peptide transport through the blood-brain barrier. Endocr. Rev. 7, 314-330 (1986).
15. Schwartz, M.W., Figlewicz, D.P., Baskin, D.G., Woods, S.C. & Porte, D., Jr. Insulin in the brain: A hormonal regulator of energy balance. Endocr. Rev. 13, 387-414 (1992).
16. Woods, S.C. et al. Insulin: Its relationship to the central nervous system and to the control of food intake and body weight. Am. J. Clin. Nutr. 42, 1063-1071 (1985).
17. Lee, G.-H. et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 379, 632-635 (1996).
18. Davson, H. & Segal, M.B. Physiology of the CSF and Blood Brain Barriers. 573-607 (CRC Press, London, 1996).